Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BackgroundThe Thai-Cambodian border has been known as the origin of antimalarial drug resistance for the past 30 years. There is a highly diverse market for antimalarials in this area, and improved knowledge of drug pressure would be useful to target interventions aimed at reducing inappropriate drug use.MethodsBaseline samples from 125 patients with falciparum malaria recruited for 2 in vivo studies (in Preah Vihear and Pursat provinces) were analyzed for the presence of 14 antimalarials in a single run, by means of a liquid chromatography-tandem mass spectrometry assay.ResultsHalf of the patients had residual drug concentrations above the lower limit of calibration for at least 1 antimalarial at admission. Among the drugs detected were the currently used first-line drugs mefloquine (25% and 35% of patients) and piperaquine (15% of patients); the first-line drug against vivax malaria, chloroquine (25% and 41% of patients); and the former first-line drug, quinine (5% and 34% patients).ConclusionsThe findings demonstrate that there is high drug pressure and that many people still seek treatment in the private and informal sector, where appropriate treatment is not guaranteed. Promotion of comprehensive behavioral change, communication, community-based mobilization, and advocacy are vital to contain the emergence and spread of parasite resistance against new antimalarials.

Original publication

DOI

10.1086/655779

Type

Journal article

Journal

The Journal of infectious diseases

Publication Date

10/2010

Volume

202

Pages

1088 - 1094

Addresses

Swiss Tropical Institute, Basel, Switzerland.

Keywords

Serum, Humans, Malaria, Falciparum, Quinine, Quinolines, Chloroquine, Mefloquine, Antimalarials, Chromatography, Liquid, Drug Resistance, Adolescent, Adult, Middle Aged, Child, Child, Preschool, Cambodia, Female, Male, Tandem Mass Spectrometry, Young Adult, Selection, Genetic